share_log

奥赛康:关于子公司马立巴韦片获得药品注册上市许可申请受理通知书的公告

Osecon: Notice on the acceptance of the application for the subsidiary Malibavir tablets to obtain approval for drug registration and marketing

SZSI ·  Jan 3
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more